Clinical Trial Update: Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy and Ofatumumab in adults with acute lymphoblastic leukemia or lymphoblastic lymphoma completed; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Burkitt Leukemia
• Burkitt Lymphoma
• Lymphoblastic Lymphoma

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission | Phase 2 | Status: COMPLETED | Results posted: 2021-05-03